Cystic Fibrosis (CF) Completed Phase 2 Trials for Mannitol (DB00742)

Also known as: CF / Mucoviscidosis / Cystic Fibrosis / Cystic fibrosis NOS

IndicationStatusPhase
DBCOND0040212 (Cystic Fibrosis (CF))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117208Comparison of Inhaled Mannitol and rhDNase in Children With Cystic FibrosisTreatment
NCT00251056Mannitol Dose Response Study in Cystic FibrosisTreatment
NCT00455130A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic FibrosisTreatment
NCT01883531Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 YearsTreatment